Hemodialysis is a medical treatment for patients with end-stage renal disease (ESRD), where the kidneys cannot filter waste & excess fluids from the blood. Hemodialysis involves using a hemodialysis machine, which filters the blood through a membrane to remove waste products and excess fluids. The treated blood is then returned to the patient’s body.

In 2021, the market for Hemodialysis was worth USD 85.49 million, and by 2030, it will be worth USD 130.36 million, at a 5.1% CAGR during the forecast period.

The prevalence of acute kidney injury (AKI), the lack of organ donors, transplant risks, technical advancements, and endeavors by the leading companies to launch new goods and services are some of the reasons driving the market.

Market Dynamics

Drivers

• Increasing prevalence of end-stage renal disease (ESRD):The prevalence of ESRD is increasing globally, primarily due to the rising incidence of chronic kidney diseases (CKD), diabetes, hypertension, and other diseases. Hemodialysis is a critical treatment for ESRD patients, driving the demand for hemodialysis products and services.
• Growing aging population: The global aging population is increasing, leading to a higher incidence of kidney diseases and related disorders. The elderly population is also more likely to suffer from comorbidities such as diabetes, hypertension, and cardiovascular diseases, which increase the risk of developing ESRD.
• Technological advancements in hemodialysis products: The hemodialysis market is witnessing significant technological advancements in hemodialysis products such as dialyzers, hemodialysis machines, and bloodlines. These advancements are improving the efficacy and safety of hemodialysis and increasing patient convenience, driving demand for these products.
• Increasing adoption of home-based hemodialysis: Home-based hemodialysis is gaining popularity among patients with ESRD, as it offers several benefits, such as reduced travel time and cost, greater independence, and improved quality of life. The increasing adoption of home-based hemodialysis drives the demand for portable hemodialysis machines and related products.

Restraints

• High cost of hemodialysis treatments: Hemodialysis treatments are costly, which can be a significant barrier to treatment for patients, particularly those in developing countries or without adequate health insurance coverage.
• Limited availability of dialysis centers: There is a shortage of dialysis centers in many regions, particularly rural areas. This limits patient access to hemodialysis treatments, which can significantly restrain the market growth.
• Complications associated with hemodialysis treatments: Hemodialysis treatments are associated with several complications, including infections, blood clots, and vascular access-related issues. These complications can impact patient outcomes and reduce patient confidence in hemodialysis as a treatment option.

Market Segmentation

By Product

The service segment held the largest market in 2021, with 54.0% of the revenue share. This is due to the rising frequency of ESRD and the number of dialysis service providers. To extend their services, a number of dialysis service providers have established new facilities throughout the world, which will support sector growth. Technological developments and other measures performed by various manufacturers would further enhance market expansion.

Furthermore, the consumables segment will expand at a 5.8% CAGR during the forecast period. The government will make large expenditures to enhance patient safety, patient-centered healthcare, and efficacy.

By End-Use

The hospital segment led the entire market in 2021 with a share of more than 81.0%. In hospitals and dialysis facilities, patients are given the best care possible thanks to a skilled and knowledgeable team of renal care experts. The segment will be propelled by the acceptance of in-center dialysis patients and the growing focus on independent dialysis facilities.

By Stage of Disease

Chronic Kidney Disease was the largest market segment. The last and most advanced stage of chronic kidney disease is known as an end-stage renal disease (ESRD). Patients with end-stage renal failure require dialysis or a kidney transplant.

Regional Analysis 

North America had the leading position with a more than 34.0% market share. The existence of important businesses, sizable government expenditures in the creation of cutting-edge medical equipment, and a fair reimbursement environment all contribute to the region’s success. Due to the rising prevalence of renal illness and chronic kidney disorders, there is an increasing need for dialysis. In addition, rising healthcare costs, government programs, and high disposable income all support market expansion.

Asia Pacific will expand at a 5.6% CAGR. Increased product development, an aging population, and increased renal disease occurrences will all contribute to market expansion.

Key Players 

• DaVita Inc
• Fresenius
• Braun
• Becton, Dickinson, and Company
• Baxter & Gambro
• NxStage
• Nipro
• Nikkiso
• Toray
• Merck KGaA
• WEGO
• Asahi Kasei
• Jihua

In 2021, the market for Hemodialysis was worth USD 85.49 million, and by 2030 it will be worth USD 130.36 million, at a 5.1% CAGR during the forecast period. The rise in the prevalence of diabetes and hypertension, the number of people with end-stage renal diseases, and the aging population are all contributing factors to the expansion of the hemodialysis market.

Related Reports:

Recombinant DNA Technology Market Report – The global recombinant DNA technology market will witness a robust CAGR of 7.7%, valued at $707.20 billion in 2021, expected to appreciate and reach $1378.76 billion by 2030, confirms Strategic Market Research.